Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Polymyxin B- and trimethoprim-containing product |
Is a |
Product containing polymyxin B (medicinal product) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Polymyxin B- and trimethoprim-containing product |
Is a |
Product containing trimethoprim (medicinal product) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Polymyxin B- and trimethoprim-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Polymyxin B |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Polymyxin B- and trimethoprim-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Trimethoprim (substance) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Polymyxin B- and trimethoprim-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
anti-infectieux cutané |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Polymyxin B- and trimethoprim-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Urinary anti-infective |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Polymyxin B- and trimethoprim-containing product |
Is a |
Product containing polymyxin B in ophthalmic dosage form |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Polymyxin B- and trimethoprim-containing product |
Has manufactured dose form |
Ocular dose form (dose form) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Polymyxin B- and trimethoprim-containing product |
Is a |
Product containing trimethoprim in ophthalmic dosage form |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Polymyxin B- and trimethoprim-containing product |
Plays role |
Antibacterial therapeutic role (role) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|